A Randomized Clinical Study (SEECASE) to Assess Efficacy, Safety, and Tolerability of NOV03 for Treatment of Dry Eye Disease

PURPOSE: NOV03 has a unique dual mode of action to address dry eye disease (DED) associated with meibomian gland dysfunction. SEECASE evaluated the efficacy, safety, and tolerability of NOV03 at 2 dosing regimens compared with a saline comparator in patients with DED. METHODS: SEECASE was a prospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Tauber, Joseph, Wirta, David L., Sall, Kenneth, Majmudar, Parag A., Willen, Daniela, Krösser, Sonja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cornea 2021
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330824/
https://www.ncbi.nlm.nih.gov/pubmed/33369937
http://dx.doi.org/10.1097/ICO.0000000000002622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330824/
https://www.ncbi.nlm.nih.gov/pubmed/33369937
http://dx.doi.org/10.1097/ICO.0000000000002622

Ejemplares similares